Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies

被引：0
|
作者：
Vashchenko, N. [1 ,2 ]
Skorobogatykh, K. [2 ]
Azimova, J. [2 ]
Korobkova, D. [2 ]
机构：
[1] Sechenov Univ, Dept Neurol, Moscow, Russia
[2] Univ Headache Clin, Moscow, Russia
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0341
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [41] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [42] CGRP antagonists and antibodies for the treatment of migraine
    Vecsei, Laszlo
    Szok, Delia
    Csati, Anett
    Tajti, Janos
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (01) : 31 - 41
  • [43] CGRP antibodies in the prophylactic treatment of migraine
    Sipkova, J.
    Nezadal, T.
    Ctrnacta, D.
    Bajacek, M.
    Dvorak, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (03) : 248 - 256
  • [44] Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, Stephane Alexandre
    Lee, Xin Ying
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1072 - 1080
  • [45] CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
    Francesca Schiano di Cola
    Salvatore Caratozzolo
    Marco Bolchini
    Giulia Ceccardi
    Matteo Cortinovis
    Paolo Liberini
    Alessandro Padovani
    Renata Rao
    Neurological Sciences, 2022, 43 : 5763 - 5764
  • [46] ANTI-CGRP MONOCLONAL ANTIBODIES FOR NEUROPATHIC PAIN IN PATIENTS WITH MIGRAINE HEADACHE
    Kang, Seung Ah
    Govindarajan, Raghav
    MUSCLE & NERVE, 2020, 62 : S7 - S7
  • [47] Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
    Kang, Seung Ah
    Govindarajan, Raghav
    NEUROLOGY, 2021, 96 (15)
  • [48] CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Bolchini, Marco
    Ceccardi, Giulia
    Cortinovis, Matteo
    Liberini, Paolo
    Padovani, Alessandro
    Rao, Renata
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5763 - 5764
  • [49] Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
    Pellesi, Lanfranco
    Do, Thien P.
    Ashina, Hakan
    Ashina, Messoud
    Burstein, Rami
    HEADACHE, 2020, 60 (06): : 1056 - 1065
  • [50] Patient-reported outcomes among migraine patients treated with cgrp-monoclonal antibodies in clinical practice
    Sanchez-Casado, L.
    Corral-Quereda, C.
    de Teran Velasco, J. Diaz
    Sastre-Real, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 119 - 119
12345